Literature DB >> 19535645

CD44high memory CD8 T cells synergize with CpG DNA to activate dendritic cell IL-12p70 production.

Kok Loon Wong1, Li Fang Melissa Tang, Fei Chuin Lew, Hok Sum Kenneth Wong, Yen Leong Chua, Paul A MacAry, David M Kemeny.   

Abstract

Protective memory CD8 T cell responses are generally associated with the rapid and efficient acquisition of CTL function. However, the ability of memory CD8 T cells to modulate immune responses through interactions with dendritic cells (DCs) during the early states of secondary Ag exposure is poorly understood. In this study, we show that murine Ag-specific CD44(high) CD8 T cells, representing CD8 T cells of the memory phenotype, potently activate DCs to produce high levels of IL-12p70 in conjunction with stimulation of DCs with the TLR 9 ligand, unmethylated CpG DNA. IL-12p70 production was produced predominantly by CD8alpha(+) DCs and plasmacytoid DCs, and mediated by CD8 T cell-derived cytokines IFN-gamma, GM-CSF, TNF-alpha, and surface CD40L. We also find that CD44(high) memory phenotype CD8 T cells were better DC IL-12p70 stimulators than CD44(low) naive phenotype CD8 T cells, and this was attributed to higher levels of IFN-gamma and GM-CSF produced by CD44(high) memory phenotype CD8 T cells during their Ag specific interaction with DCs. Our study identifies CpG DNA as the most effective TLR ligand that cooperates with CD8 T cells for DC IL-12p70 production, and suggests that effectiveness of memory CD8 T cells could be attributed to their ability to rapidly and effectively induce protective Th1 immunity during early stages of pathogen reinfection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535645     DOI: 10.4049/jimmunol.0803473

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Adipocytes: A Novel Target for IL-15/IL-15Rα Cancer Gene Therapy.

Authors:  Run Xiao; Anthony G Mansour; Wei Huang; Logan A Chrislip; Ryan K Wilkins; Nicholas J Queen; Youssef Youssef; Hsiaoyin C Mao; Michael A Caligiuri; Lei Cao
Journal:  Mol Ther       Date:  2019-02-16       Impact factor: 11.454

Review 2.  Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.

Authors:  Pawel Kalinski; Hideho Okada
Journal:  Semin Immunol       Date:  2010-04-20       Impact factor: 11.130

3.  Generation of αGal-enhanced bifunctional tumor vaccine.

Authors:  Jian He; Yu Huo; Zhikun Zhang; Yiqun Luo; Xiuli Liu; Qiaoying Chen; Pan Wu; Wei Shi; Tao Wu; Chao Tang; Huixue Wang; Lan Li; Xiyu Liu; Yong Huang; Yongxiang Zhao; Lu Gan; Bing Wang; Liping Zhong
Journal:  Acta Pharm Sin B       Date:  2022-03-09       Impact factor: 14.903

Review 4.  Immunotherapy of cancer in 2012.

Authors:  John M Kirkwood; Lisa H Butterfield; Ahmad A Tarhini; Hassane Zarour; Pawel Kalinski; Soldano Ferrone
Journal:  CA Cancer J Clin       Date:  2012-05-10       Impact factor: 508.702

5.  CpG and interleukin-15 synergize to enhance IFN-γ production by activated CD8+ T cells.

Authors:  Dustin Cobb; Siqi Guo; Ronald B Smeltz
Journal:  Biomed Res Int       Date:  2012-12-23       Impact factor: 3.411

6.  A self-help program for memory CD8+ T cells: positive feedback via CD40-CD40L signaling as a critical determinant of secondary expansion.

Authors:  Jessica A Shugart; Shelly Bambina; Alejandro F Alice; Ryan Montler; Keith S Bahjat
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

7.  CD40L Expression Allows CD8+ T Cells to Promote Their Own Expansion and Differentiation through Dendritic Cells.

Authors:  Neil Q Tay; Debbie C P Lee; Yen Leong Chua; Nayana Prabhu; Nicholas R J Gascoigne; David M Kemeny
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.